06:03 EDT Cyclacel Pharmaceuticals files to sell common stock, warrants, no amount given Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on CYCC: Cyclacel completes enrollment in Cohort 8 of Phase 2 study of fadraciclib Cyclacel Pharmaceuticals confirms filing of appeal to Nasdaq delisting letter Eleven option delistings on August 19th Cyclacel Pharmaceuticals reports Q2 EPS (72c), consensus ($1.43) Disclaimer & DisclosureReport an Issue
